The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2024

Filed:

Nov. 17, 2020
Applicant:

Sorriso Pharmaceuticals, Inc., San Diego, CA (US);

Inventors:

Scott Crowe, Cambridge, GB;

Mike West, Cambridge, GB;

Kevin Roberts, Cambridge, GB;

Tim Carlton, Cambridge, GB;

Assignee:

SORRISO PHARMACEUTICALS, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/12 (2006.01); C07K 16/24 (2006.01); G01N 33/53 (2006.01); G01N 33/577 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1282 (2013.01); C07K 16/241 (2013.01); C07K 16/2866 (2013.01); A61K 2039/542 (2013.01); C07K 2317/22 (2013.01); C07K 2317/35 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); G01N 33/53 (2013.01); G01N 33/577 (2013.01); Y02A 50/30 (2018.01);
Abstract

Described herein is a polypeptide comprising an immunoglobulin chain variable domain comprising three complementarity determining regions (CDR1-CDR3) and four framework regions, wherein: (a) at least one lysine residue in CDR1, CDR2 and/or CDR3 has been substituted with at least one histidine residue, and/or (b) at least one arginine residue in CDR1, CDR2 and/or CDR3 has been substituted with at least one histidine residue. The polypeptides of this disclosure possess increased intestinal stability relative to a corresponding polypeptide not having the histidine substitutions.


Find Patent Forward Citations

Loading…